INFRAFRONTIER / IMPC Stakeholder Meeting 2018

The second Stakeholder Meeting of INFRAFRONTIER, the European Research Infrastructure for phenotyping and archiving of model mammalian genomes, will be jointly organized with the International Mouse Phenotyping Consortium (IMPC). It will take place on December 3-4, 2018 in Munich, Germany. The focus of this year's event is on advancing Rare Disease research and gene therapy applications with animal models. The sessions' topics have been announced as follows:

CureCN coordinator Federico Mingozzi from Genethon will give a key note on "Gene therapy treatment for a rare liver disease, Crigler-Najjar Syndrome" in Session 4 "Animal models for human gene therapy applications" on December 4, 2018 between 08:30 and 10:00.

For more information, visit the Stakeholder Meeting's website.